Endoscopic considerations in gastroesophageal reflux disease

W. Scott Melvin, Jeffrey L. Eakin

Research output: Chapter in Book/Report/Conference proceedingChapter


Gastroesophageal reflux disease affects approximately 50 million Americans and some studies estimate the prevalence approaches 20 % of the population in many Western countries. Approximately 50 % of the U.S. population experiences gastroesophageal reflux disease astroesophageal reflux disease-related symptoms once a month, and one in ten Americans experience symptoms of heartburn and bloating every day. This tremendously prevalent condition has had and will continue to have a significant economic impact on the Unites States and other developed Western countries. In view of that, numerous countries expend a considerable amount of resources on direct and indirect costs attributable to the prevention and treatment of reflux disease. Gastroesophageal reflux disease has a substantial impact on clinical and financial welfare since patients suffering from this disorder generally report a diminished health-related quality of life (HRQL), reduced work productivity, and depressed psychological health.

Original languageEnglish (US)
Title of host publicationPrinciples of Flexible Endoscopy for Surgeons
PublisherSpringer New York
Number of pages10
ISBN (Electronic)9781461463306
ISBN (Print)1461463297, 9781461463290
StatePublished - Oct 1 2013
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Endoscopic considerations in gastroesophageal reflux disease'. Together they form a unique fingerprint.

Cite this